Docetaxel, estramustine, and short-term androgen withdrawal for patients with biochemical failure after definitive local therapy for prostate cancer. [electronic resource]
Producer: 20011204Description: 32-9 p. digitalISSN:- 0093-7754
- Adenocarcinoma -- blood
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Docetaxel
- Estramustine -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- blood
- Paclitaxel -- administration & dosage
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Taxoids
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.